首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen
【2h】

A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen

机译:鼻内和/或联合免疫表达减毒鼠伤寒沙门氏菌表达鼠疫耶尔森氏菌F1和V抗原的小鼠的免疫原性和针对实验鼠疫的保护性免疫的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We investigated the relative immunogenicity and protective efficacy of recombinant X85MF1 and X85V strains of ΔcyaΔcrpΔasd-attenuated Salmonella Typhimurium expressing, respectively, secreted Yersinia pestis F1 and V antigens, following intranasal (i.n.) or i.n. combined with oral immunization for a mouse model. A single i.n. dose of 108 CFU of X85MF1 or X85V induced appreciable serum F1- or V-specific IgG titres, although oral immunization did not. Mice i.n. immunized three times (i.n. × 3) with Salmonella achieved the most substantial F1/V-specific IgG titres, as compared with corresponding titres for an oral-primed, i.n.-boosted (twice; oral-i.n. × 2) immunization regimen. The level of V-specific IgG was significantly greater than that of F1-specific IgG (P<0.001). Analysis of the IgG antibodies subclasses revealed comparable levels of V-specific Th-2-type IgG1 and Th-1-type IgG2a, and a predominance of F1-specific Th-1-type IgG2a antibodies. In mice immunized intranasally, X85V stimulated a greater IL-10-secreting-cell response in the lungs than did X85MF1, but impaired the induction of gamma-interferon-secreting cells. A program of i.n. × 3 and/or oral-i.n. × 2 immunization with X85V provided levels of protection against a subsequent lethal challenge with Y. pestis, of, respectively, 60% and 20%, whereas 80% protection was provided following the same immunization but with X85MF1.
机译:我们研究了鼻内(i.n.)或i.n.后分别表达分泌的鼠疫耶尔森菌F1和V抗原的ΔcyaΔcrpΔasd减毒鼠伤寒沙门氏菌的重组X85MF1和X85V菌株的相对免疫原性和保护功效。结合口服免疫小鼠模型。单身剂量为10 8 CFU的X85MF1或X85V诱导了明显的血清F1-或V-特异性IgG滴度,尽管口服免疫没有。小鼠沙门氏菌免疫3次(i.n.×3)达到了最明显的F1 / V特异性IgG滴度,而口服预免疫,n.n。加强(两次;口服i.n.×2)免疫方案的相应滴度则更高。 V特异性IgG的水平显着高于F1特​​异性IgG的水平(P <0.001)。对IgG抗体亚类的分析显示,V特异性Th-2-型IgG1和Th-1-型IgG2a的水平相当,而F1特异性Th-1型IgG2a抗体占优势。在鼻内免疫的小鼠中,与X85MF1相比,X85V在肺中刺激的IL-10分泌细胞反应更大,但会削弱γ-干扰素分泌细胞的诱导。 i.n.的程序×3和/或口头通知X85V的×2免疫提供了针对随后的鼠疫耶尔森氏菌致命致死性攻击的保护水平,分别为60%和20%,而相同的免疫接种但使用X85MF1提供了80%的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号